Appendix B: Panel Roster and Financial Disclosures
Herpes (HSV/VZV)
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| John Gnann | Medical University of South Carolina | GlaxoSmithKline | Consultant |
| BioCryst | Data Safety Monitoring Board | ||
| Gary Holland | David Geffen School of Medicine at the University of California, Los Angeles | None | N/A |
| Christine Johnston | University of Washington School of Medicine | Gilead Sciences AbbVie | Consultant |
| Poonam Mathur | University of Washington School of Medicine | None | N/A |
| Shannon Ross | The University of Alabama at Birmingham Marnix E. Heersink School of Medicine | None | N/A |
| Sarah Schmalzle* | University of Maryland, Institute of Human Virology | Thera Technologies Gilead Sciences | Research Support (paid to institution) |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. | |||
Download Guidelines
- Section Only PDF (21.56 KB)
- Full Guideline PDF (6 MB)
- Tables Only PDF (928.12 KB)